NCT02421484View on ClinicalTrials.gov

Cellular Immunotherapy for Septic Shock: A Phase I Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

October 30, 2018

Conditions
Septic Shock
Interventions
BIOLOGICAL

Allogeneic mesenchymal stromal cells

The allogeneic mesenchymal stromal cells will be administered intravenously.

Trial Locations (1)

K1H 8L9

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Hospital Research Institute

OTHER